Press Release Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results Aug 13
Press Release Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma Aug 10